Handelsbanken Fonder’s Ultragenyx Pharmaceutical RARE Stock Holding History

Handelsbanken Fonder’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.32M	Buy	39,523 +6,000	+18%	+$149K	﹤0.01%	1010
2026 Q1	$702K	Hold	33,523	–	–	﹤0.01%	1190
2025 Q4	$771K	Buy	33,523 +6,400	+24%	+$210K	﹤0.01%	1161
2025 Q3	$816K	Hold	27,123	–	–	﹤0.01%	1086
2025 Q2	$986K	Sell	27,123 -100	-0.4%	-$3.6K	﹤0.01%	969
2025 Q1	$986K	Hold	27,223	–	–	﹤0.01%	947
2024 Q4	$1.15M	Buy	27,223 +2,700	+11%	+$134K	﹤0.01%	912
2024 Q3	$1.36M	Buy	24,523 +3,200	+15%	+$163K	0.01%	815
2024 Q2	$876K	Buy	21,323 +6,700	+46%	+$286K	﹤0.01%	897
2024 Q1	$683K	Hold	14,623	–	–	﹤0.01%	1016
2023 Q4	$699K	Hold	14,623	–	–	﹤0.01%	964
2023 Q3	$521K	Hold	14,623	–	–	﹤0.01%	1032
2023 Q2	$675K	Sell	14,623 -3,000	-17%	-$139K	﹤0.01%	910
2023 Q1	$707K	Buy	17,623 +5,400	+44%	+$232K	﹤0.01%	832
2022 Q4	$566K	Buy	12,223 +1,700	+16%	+$66.9K	﹤0.01%	900
2022 Q3	$436K	Hold	10,523	–	–	﹤0.01%	1045
2022 Q2	$628K	Hold	10,523	–	–	﹤0.01%	895
2022 Q1	$764K	Hold	10,523	–	–	﹤0.01%	917
2021 Q4	$885K	Hold	10,523	–	–	﹤0.01%	958
2021 Q3	$949K	Hold	10,523	–	–	0.01%	933
2021 Q2	$1M	Sell	10,523 -600	-5%	-$62.5K	0.01%	918
2021 Q1	$1.27M	Buy	11,123 +1,100	+11%	+$150K	0.01%	743
2020 Q4	$1.39M	Hold	10,023	–	–	0.01%	699
2020 Q3	$824K	Buy	10,023 +1,400	+16%	+$116K	0.01%	788
2020 Q2	$674K	Buy	+8,623	New	+$571K	0.01%	826
2016 Q4	–	Sell	-8,000	Closed	-$568K	–	169
2016 Q3	$568K	Hold	8,000	–	–	0.02%	156
2016 Q2	$391K	Hold	8,000	–	–	0.02%	168
2016 Q1	$506K	Sell	8,000 -8,000	-50%	-$523K	0.02%	153
2015 Q4	$1.79M	Buy	+16,000	New	+$1.6M	0.03%	370

Other funds holding RARE

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

AWM

Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

FISPB

Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM

OAM

OP Asset Management Helsinki $9.38B AUM 42.35% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Handelsbanken Fonder's RARE Position: Q2 2026 in Review

Handelsbanken Fonder increased its Ultragenyx Pharmaceutical (RARE) stake by 18% in Q2 2026, buying an estimated $149K and bringing the position to 39,523 shares worth $1.32M. The position accounts for ﹤0.01% of the portfolio, ranked #1010.

Handelsbanken Fonder first reported a position in RARE in Q4 2015 and has held it in 29 quarters since. The position peaked at $1.79M in Q4 2015. 53 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

Handelsbanken Fonder held 39,523 shares of Ultragenyx Pharmaceutical worth $1.32M as of Q2 2026.
Handelsbanken Fonder bought 6,000 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $149K.
Ultragenyx Pharmaceutical made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #1010 holding.
Handelsbanken Fonder first reported a position in Ultragenyx Pharmaceutical in Q4 2015 and has held it in 29 quarters since.
Handelsbanken Fonder's Ultragenyx Pharmaceutical position peaked at $1.79M in Q4 2015.
53 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.